倍他米松联合生长抑素治疗术后早期炎性肠梗阻疗效分析  

Therapeutic Effect Analysis of Betamethasone Sodium Phosphate and Somatostatin for Treatment of Early Postoperative in Flammatory Small Bowel

作　　者：申志新[1] 高海玲[2] 李国强[1] 李佩瑞[1] 步同亮 姜俊怡[1] 

机构地区：[1]潍坊医学院附属医院普外科,山东潍坊261031 [2]潍坊医学院组织胚胎学教研室 [3]坊子区医院肾内科

出　　处：《潍坊医学院学报》2008年第5期449-450,共2页Acta Academiae Medicinae Weifang

摘　　要：目的探讨倍他米松（舒其松）和生长抑素联合应用在治疗术后早期炎性肠梗阻中的疗效。方法1996年9月-2005年9月,我院普外科收治的83例术后早期炎性肠梗阻病人随机分为两组,常规治疗54例（对照组）与加用倍他米松和生长抑素8肽（善宁）治疗29例（观察组）作对比分析,观察其治愈时间和治疗效果。结果观察组的平均治愈时间较对照组显著缩短（t=9.21,P〈0.01）;观察组和对照组中分别有5例和14例结合手术治愈,在非手术治疗的疗效方面两者无明显差别（χ^2=0.48,P〉0.05）。结论倍他米松和生长抑素的应用可以明显缩短术后早期炎性肠梗阻患者的治愈时间,减少住院天数。Objective To investigate the effect of betamethasone sodium phosphate（BSP） and somatostatin for treatment of early postoperative inflammatory small bowel.Methods Eighty-three cases of EPISBO from 1996～2005 randomly divide into conventional therapy group（54 cases） and BSP group（29 cases）,to observe time of therapy and therapeutic efficacy.Results The average curative time of the BSP group is much shorter than the control group（t=9.21,P〈0.01）;Five patients healing well by surgical intervention in the BSP group and 14 patients in the control group.There is no significant difference on therapeutic effect of expectant treatment（χ^2=0.48,P〉0.05）.Conclusion The application of BSP and somatostatin may obviously shorten the average curative time for the patients wih EPISBO.

关 键 词：倍他米松 生长抑素 术后早期炎性肠梗阻 术后并发症 

分 类 号：R574.2[医药卫生—消化系统]